Actively Recruiting
Study of Blood Sugar and Bowel Symptoms After a Meal in IBS Patients with Different Sucrase-Isomaltase Gene Types
Led by Region Skane · Updated on 2026-04-29
70
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are examining whether patients with irritable bowel syndrome IBS who have a reduced ability to break down starch and sugar due to lower enzyme levels experience a smaller rise in blood glucose after a meal compared to those with normal enzyme levels. The study also aims to see if these patients have more bowel symptoms following the meal. This interventional study focuses on the relationship between enzyme function and blood sugar and symptom changes in IBS patients. Participants, all previously tested genetically for sucrase-isomaltase SI and other carbohydrate absorption enzymes, will complete lifestyle and symptom questionnaires at home before attending the clinic fasting. During the visit, a plastic tube is placed in the arm for blood sampling, and participants eat a sugar-rich meal over 15 minutes. Blood samples for glucose measurement are taken before, during, and at various times up to 2 hours after the meal, alongside symptom questionnaires. The study will compare the changes in blood glucose and bowel symptoms between those with reduced and normal enzyme activity. Researchers will analyze how blood sugar levels relate to symptoms. The total observation period for measuring outcomes after the meal is 2 hours, with symptom assessments done simultaneously. This study also collects detailed symptom scores using visual analog scales and IBS severity scoring systems.
CONDITIONS
Brief Title
Sucrase-Isomaltase (SI) Genes and Meal Load
Research Team
B
Bodil Ohlsson C Professor, MD, PhD
M
Mauro D'Amato Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here